OBJECTIVE: The objective of this study was to identify the vital status and reasons for children becoming loss to follow-up (LTFU) from a large program in western Kenya. METHODS: This was a prospective evaluation of a random sample of 30% of HIV-exposed and HIV-positive children LTFU from either an urban or rural HIV Academic Model Providing Access to Healthcare clinic. LTFU is defined as absence from clinic for >6 months if on combination antiretroviral therapy and > 12 months if not. Experienced community health workers were engaged to locate them. RESULTS: There were 97 children sampled (78 urban, 19 rural). Of these, 82% were located (78% urban, 100% rural). Among the HIV positive, 16% of the children were deceased, and 16% had not returned to clinic because of disclosure issues/discrimination in the family or community. Among the HIV exposed, 30% never returned to care because their guardians either had not disclosed their own HIV status or were afraid of family/community stigma related to their HIV status or that of the child. Among children whose HIV status was unknown, 29% of those found had actually died, and disclosure/discrimination accounted for 14% of the reasons for becoming LTFU. Other reasons included believing the child was healed by faith or through the use of traditional medicine (7%), transport costs (6%), and transferring care to other programs or clinics (8%). CONCLUSION: After locating >80% of the children in our sample, we identified that mortality and disclosure issues including fear of family or community discrimination were the most important reasons why these children became LTFU.
OBJECTIVE: The objective of this study was to identify the vital status and reasons for children becoming loss to follow-up (LTFU) from a large program in western Kenya. METHODS: This was a prospective evaluation of a random sample of 30% of HIV-exposed and HIV-positive children LTFU from either an urban or rural HIV Academic Model Providing Access to Healthcare clinic. LTFU is defined as absence from clinic for >6 months if on combination antiretroviral therapy and > 12 months if not. Experienced community health workers were engaged to locate them. RESULTS: There were 97 children sampled (78 urban, 19 rural). Of these, 82% were located (78% urban, 100% rural). Among the HIV positive, 16% of the children were deceased, and 16% had not returned to clinic because of disclosure issues/discrimination in the family or community. Among the HIV exposed, 30% never returned to care because their guardians either had not disclosed their own HIV status or were afraid of family/community stigma related to their HIV status or that of the child. Among children whose HIV status was unknown, 29% of those found had actually died, and disclosure/discrimination accounted for 14% of the reasons for becoming LTFU. Other reasons included believing the child was healed by faith or through the use of traditional medicine (7%), transport costs (6%), and transferring care to other programs or clinics (8%). CONCLUSION: After locating >80% of the children in our sample, we identified that mortality and disclosure issues including fear of family or community discrimination were the most important reasons why these children became LTFU.
Authors: Paula Braitstein; Adrian Katshcke; Changyu Shen; Edwin Sang; Winstone Nyandiko; Vincent Ooko Ochieng; Rachel Vreeman; Constantin T Yiannoutsos; Kara Wools-Kaloustian; Samwel Ayaya Journal: Trop Med Int Health Date: 2010-05-14 Impact factor: 2.622
Authors: Megan McGuire; Tamika Munyenyembe; Elisabeth Szumilin; Annette Heinzelmann; Mickael Le Paih; Nenette Bouithy; Mar Pujades-Rodríguez Journal: Trop Med Int Health Date: 2010-06 Impact factor: 2.622
Authors: Rachel C Vreeman; Winstone M Nyandiko; Samwel O Ayaya; Eunice G Walumbe; David G Marrero; Thomas S Inui Journal: AIDS Patient Care STDS Date: 2010-10 Impact factor: 5.078
Authors: J P Ioannidis; T E Taha; N Kumwenda; R Broadhead; L Mtimavalye; P Miotti; F Yellin; D G Contopoulos-Ioannidis; R J Biggar Journal: Int J Epidemiol Date: 1999-08 Impact factor: 7.196
Authors: Rachel C Vreeman; Winstone M Nyandiko; Samwel O Ayaya; Eunice G Walumbe; David G Marrero; Thomas S Inui Journal: Qual Health Res Date: 2009-12
Authors: Paula Braitstein; Winstone Nyandiko; Rachel Vreeman; Kara Wools-Kaloustian; Edwin Sang; Beverly Musick; John Sidle; Constantin Yiannoutsos; Samwel Ayaya; E Jane Carter Journal: Pediatr Infect Dis J Date: 2009-07 Impact factor: 2.129
Authors: Constantin T Yiannoutsos; Ming-Wen An; Constantine E Frangakis; Beverly S Musick; Paula Braitstein; Kara Wools-Kaloustian; Daniel Ochieng; Jeffrey N Martin; Melanie C Bacon; Vincent Ochieng; Sylvester Kimaiyo Journal: PLoS One Date: 2008-12-02 Impact factor: 3.240
Authors: Kathy Goggin; Emily A Hurley; Vincent S Staggs; Catherine Wexler; Niaman Nazir; Brad Gautney; Samoel A Khamadi; May Maloba; Raphael Lwembe; Sarah Finocchario-Kessler Journal: AIDS Patient Care STDS Date: 2019-08 Impact factor: 5.078
Authors: Edwin Masese Machine; Susan L Gillespie; Nuria Homedes; Beatrice J Selwyn; Michael W Ross; Gabriel Anabwani; Gordon Schutze; Mark W Kline Journal: AIDS Care Date: 2016-05-10
Authors: Awachana Jiamsakul; Azar Kariminia; Keri N Althoff; Carina Cesar; Claudia P Cortes; Mary-Ann Davies; Viet Chau Do; Brian Eley; John Gill; Nagalingeswaran Kumarasamy; Daisy Maria Machado; Richard Moore; Hans Prozesky; Elizabeth Zaniewski; Matthew Law Journal: J Acquir Immune Defic Syndr Date: 2017-11-01 Impact factor: 3.731
Authors: B Ryan Phelps; Saeed Ahmed; Anouk Amzel; Mamadou O Diallo; Troy Jacobs; Scott E Kellerman; Maria H Kim; Nandita Sugandhi; Melanie Tam; Megan Wilson-Jones Journal: AIDS Date: 2013-11 Impact factor: 4.177